CSI Market
Sign In | Register

Biolinerx Ltd (BLRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BLRX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Biolinerx Ltd's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents3.25
Cash & Short-term Investments3.00
Inventories2.15
Other Current Assets18.28
Total Current Assets23.68
Equipment/Property/Plant Net0.16
Intangible Assets16.37
Other Assets, Noncurrent0.70
Total Assets40.91
Liabilities
Other Liabilities, Current12.12
Total Current Liabilities12.12
Total Long-term Debt0.00
Other liabilities, Noncurrent5.44
Total Liabilities17.56
Stockholders' Equity
Other Equity23.35
Common Stockholder's Equity23.35
Total Stockholder's Equity23.35
Liabilities & Stockholder's Equity40.91
4 historic quarters locked

Sign in to unlock the full Biolinerx Ltd balance sheet history.

Sign In Create Free Account

About Biolinerx Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 23, 2026
  • Source: zk2634707.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-001581

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.